Goldman Sachs expects companies to keep channeling the bulk of their cash toward capital expenditures and research and ...

Penn State's research enterprise reached a new milestone in fiscal year 2024-25 with $1.44 billion in total research ...

According to Acumen Research and Consulting, the global Personalized Medicine Biomarkers Market was valued at USD 20.95 billion in 2024 and is projected to reach USD 72.06 billion by 2033, growing at ...

Tesla  reported record third-quarter revenue that beat Wall Street estimates on Wednesday, driven by the highest quarterly ...

The Surgical Performance Center--powered by the University of Maryland School of Medicine and Axis and will serve as a national model for surgical training and innovation. Construction is anticipated ...

Tesla (NASDAQ: TSLA) posted record third-quarter revenue that surpassed Wall Street forecasts, driven by strong electric ...

PACCAR Inc (PCAR) reports robust financial performance with record parts revenue and strategic expansions, despite facing ...

Gold and silver face sharp declines, with silver in correction territory and gold down 8%, driven by technical trading and ...

PACCAR achieved net income of $590.0 million ($1.12 per diluted share) in the third quarter of this year compared to $972.1 ...

Operating expenses soared 50 per cent to US$3.4 billion in the quarter, while Tesla expects a tariff hit of about US$400 ...

Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, announced today that, ...